High Copayments For "Specialty Pharmacy" Medications Has Little Effect On Use, Report Says
Main Category: Health Insurance / Medical InsuranceAlso Included In: Cancer / Oncology; Multiple Sclerosis
Article Date: 14 Sep 2006 - 17:00 PDT
| Patient / Public: | ![]() |
3 (2 votes) |
| Healthcare Prof: | ![]() |
4 (1 votes) |
Higher copayments have a small effect on usage of "specialty pharmacy" medications, which can cost as much as $10,000 monthly, according to a study published Tuesday in the journal Health Affairs, the Pittsburgh Post-Gazette reports. Health insurers often place specialty pharmacy medications -- injectable and biological medications that target a gene or protein and often are used to treat complex chronic conditions such as anemia, cancer and multiple sclerosis -- on the "fourth tier" of prescription drug formularies and require members to pay 25% copays for the treatments, with maximum out-of-pocket payments of $1,000 annually. However, the study, led by Dana Goldman, chair and director for health economics at RAND, finds that higher copays for specialty pharmacy medications reduce usage by only 1% to 21%, compared with 30% to 50% for traditional treatments. "Insurance markets work best when there is the chance of substantial loss, when that loss is sufficiently rare and uncertain, and when the presence of coverage will not alter behavior much," according to the study. As a result, specialty pharmacy medications "appear to warrant greater, not less, coverage than traditional pharmaceutical agents," the study finds. Goldman said, "Patients are desperate for these drugs, and they're willing to pay quite a bit to try whatever is out there," adding, "Even though they're expensive, that cost is spread over a very large insurance pool, so, socially, it makes sense that we should cover them" (Snowbeck, Pittsburgh Post-Gazette, 9/12).
The study is available online.
"Reprinted with permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation . © 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.
Visit our health insurance / medical insurance section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/51745.php>
APA
http://www.medicalnewstoday.com/releases/51745.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




